Detection of extended spectrum β-lactamase OXA-141 in Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis

Maribel González-Villa, Rosa María Ribas-Aparicio, Rafael Coria-Jiménez, Jenny Elizabeth Donis-Rocandio, Gerardo Aparicio-Ozores

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Introduction: The aims of this research were to study the presence of extended spectrum β-lactamases (ESBL) to investigate the location of the genes encoding these enzymes, and determine the clonal relationship of strains of ceftazidime-resistant Pseudomonas aeruginosa isolated from Mexican patients with cystic fibrosis. Methods: We determined the resistance profile to 11 antibiotics (CLSI) and phenotypic ESBL detection following a disk diffusion method adapted for P. aeruginosa. Characterization of ESBL genes and integrons was performed by polymerase chain reaction (PCR) and DNA sequencing, while analysis of the clonal relationship was performed by pulsed field gel electrophoresis (PFGE). Results: Of the 148 strains studied, 22 were resistant to ceftazidime, and analysis by PCR and sequencing revealed the presence of the gene blaOXA-141 in 7 strains, 6 of which were resistant and one, susceptible to ceftazidime. In addition, blaGES was detected in 11 strains. intI2 and intI3 genes were not detected by PCR, but in the 6 ceftazidime-resistant strains, the blaOXA-141 gene was determined in a class 1 integron. Analysis of the clonal relationship of isolates showed that the majority of patients were infected during the study period with P. aeruginosa strains that exhibit different patterns, especially in individuals without a familial relationship. Conclusions: This report demonstrates the existence of the blaOXA-141 gene associated with a class 1 integron in several strains of P. aeruginosa, as well as blaGES genes, and their location and variants are being studied by our research group. This, combined with the diversity of strains able to infect several susceptible individuals, suggests the risk of spread of P. aeruginosa-strain ESBL producers among Mexican populations with cystic fibrosis. © 2011 Elsevier España, S.L. All rights reserved.
Original languageAmerican English
Pages (from-to)535-541
Number of pages480
JournalEnfermedades Infecciosas y Microbiologia Clinica
DOIs
StatePublished - 1 Nov 2012

Fingerprint Dive into the research topics of 'Detection of extended spectrum β-lactamase OXA-141 in Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis'. Together they form a unique fingerprint.

  • Cite this